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INTRODUCTION
Cesarean delivery occurs in approximately 32% of deliveries 
in the United States [1]. Th e most conventional methods for 
postoperative pain control for these patients include IV narcotic 
pain medication (either intermittent or through Patient Controlled 
Analgesia (PCA)), intrathecal long-acting narcotics and/or oral 
narcotic with or without NSAIDs. Th ese methods provide acceptable 
pain relief but are nursing intensive and have the potential for adverse 
eff ects including patient sedation, reduced mentation, respiratory 
depression, and decreased bowel function [2]. Moreover, narcotics 
have the disadvantage of being excreted into breast milk [3]. Patients 
oft en desire to withhold or minimize narcotic administration due 
to these side eff ects and concerns including safety and addiction 
potential. Th ese issues and other extraneous factors result in 
postoperative obstetrical pain control that is oft en suboptimal. High 
quality postoperative analgesia is very important for the recovery 
of the patient. Th ere are many options available, but tailoring the 
method of choice to each patient can be problematic. In addition, 
predicting the severity of an individual’s post-operative pain or the 
patient’s response to the regimen continues to be a challenge [4]. A 
locally delivered, patient controlled method would be advantageous. 
Th e use of the iFlow On-Q™ wound irrigation system for localized 
pain control has been shown to be eff ective for reducing narcotic use 
aft er abdominal surgery [5-8]. Randomized controlled trials have 
demonstrated the eff ectiveness of wound irrigation versus placebo for 
reducing narcotic use aft er Cesarean delivery [9]. Th ere is a growing 
literature examining its use aft er obstetrical surgery where placement 
of the catheter has been examined at several positions including at the 
fascial or below the sub-fascial planes. However, diff erences in study 
designs and the inconsistency in the catheter placement hampers 
interpretation of the fi ndings [7]. To our knowledge, when the wound 
irrigation system catheter has been placed at the subcutaneous tissue 
above the fascial plane, patients receiving bupivacaine had lower 
narcotic use when compared to patients receiving saline, however 
the medication group did not report lower pain scores [2]. When 
the wound irrigation system catheter was placed at the sub-fascial 
plane, it was superior in reducing narcotic use and pain when 
compared to postoperative multimodal systemic analgesia that 
included acetaminophen, nefopam, celecobix, and patient controlled 
intravenous morphine for 24 hours [10]. In contrast, with placement 
at the sub-fascial plane, patients receiving levobupivacaine by 
epidural (and saline by catheter) had lower pain scores during the 
fi rst four hours aft er surgery than patients receiving levobupivacaine 
by catheter (and saline by epidural), though aft er four hours, both 
groups had similar pain scores and both had similar total narcotic 
use [11]. In a randomized study by Rackelboom et al, patients who 
received the wound irrigation system catheter placement below the 
fascia, had lower narcotics use and lower pain scores compared to 
those patients with catheter placement above the fascia [12]. To date, 
no study has examined pain control using a local wound irrigation 
to both the sub-fascial plane and uterine incision via placement of a 
dual catheter system. Th e purpose of the study was to investigate the 
effi  cacy of continuous wound irrigation system with local anesthetic 
to both the sub-fascial plane and the overlying uterine incision in the 
peritoneal cavity aft er Cesarean section for the reduction of post-
operative pain and narcotic use. 
METHODS
Th is study was a randomized, double-blind, placebo controlled 
trial that was conducted under a research protocol (IRB # 3179) 
approved by the Wright State University Institutional Review Board 
(Dayton, Ohio). Informed consent was obtained from all patients 
prior to their involvement in the trial and the study was compliant 
with the Health Insurance Portability and Accountability Act of 1996 
(HIPAA). 
Patient Selection
Fift y patients were recruited from the house staff  service at Miami 
Valley Hospital in Dayton, Ohio from May 2013 to February 2015. 
Inclusion criteria included individuals undergoing non-emergent 
low transverse Cesarean section via pfannensteil incision under 
epidural or spinal anesthesia who were between 16 and 45 years old. 
Patients were excluded from participation if they were known to have 
a coagulopathy, sensitivity to any medications used in the study, or 
received Duramorph (long-acting morphine) as part of their pre-
delivery anesthetic regimen. A resident or faculty physician counseled 
patients about participation in the study prior to the procedure. Th ose 
interested in participating provided informed consent and signed the 
appropriate consent forms for their procedure and for participation 
in the study. Minors participating were granted permission from a 
guardian. Patients were randomized in a 1:1 group allocation to 
receive an anesthetic system fi lled with normal saline or 0.25% of 
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bupivacaine. Randomization using a random numbers generator was 
performed by the pharmacy staff  at Miami Valley Hospital. Physicians 
performing the surgery, researchers, nursing staff , and patients were 
all blinded regarding the assignment to local anesthetic or placebo. 
Systems were labeled only with participant’s study identifi cation 
number. Resident physicians, under supervision from attending 
physicians, performed all Cesarean sections and placed the wound 
irrigation system catheter in a standardized fashion.
On - Q™ Wound Irrigation System Catheter
A dual catheter iFlow On - Q™ wound irrigation system was placed 
with one catheter between the fascia and the rectus muscles and one 
catheter overlying the uterine incision in the peritoneal cavity. Th e 
catheters were introduced in the usual fashion through the skin 
utilizing separate skin punctures approximately 5 cm superior and/
or lateral to the skin incision. All patients received either bupivacaine 
or saline solution via the wound irrigation system. Additionally, 
each patient received ketorolac on a scheduled IV basis (30mg 
immediately post-operative and every 6 hours for the fi rst 24 post-
operative hours). Narcotic pain control was achieved through the 
use of a morphine PCA for the fi rst 24 hours and oral hydrocodone/
acetaminophen (Lortab 5/325mg) tablets thereaft er with intermittent 
IV morphine dosing if needed for breakthrough pain. Th e amount 
of morphine used was documented for the fi rst 24 hours. Aft er 24 
hours, total opioid use was calculated using an opioid equivalence of 
3mg PO hydrocodone to 1mg IV morphine. Postoperative pain was 
assessed in the recovery room and at 6, 12, 24, and 48 hours post-
operatively using an 11 - point Likert visual analog pain scale. Nursing 
staff  who were educated in the study protocol documented patient 
reported pain on the visual analog pain scale and documented total 
narcotic use in the medical record. All catheters were removed on the 
morning of Post Operative Day #3 by the house staff , if the patient 
was still hospitalized, or by the patient at home if she had already been 
discharged home. Catheters were removed in accordance with the 
recommendations of the manufacturer. If patients were discharged 
home with catheters in place, a resident or attending physician, prior 
to discharge, instructed them how to remove the catheters. Patients 
were also provided with the preprinted On - Q™ patient guide to 
catheter removal. If a patient had diffi  culty removing the catheter or 
did not feel comfortable removing the catheter themselves at home 
they were given an appointment for catheter removal in the offi  ce. 
Outcomes
Th e primary outcome was total narcotics used for the fi rst 48 hours 
post-operatively. An opioid equivalence of 3mg PO hydrocodone 
to 1mg IV morphine was used to convert PO hydrocodone before 
calculation of the total narcotics used. Secondary measures included 
subjective assessment of post-operative pain at 6, 12, 24, and 48 hours. 
Baseline characteristics included age, race, gravidity, parity, and Body 
Mass Index (BMI) were recorded.
Statistical Analysis
Statistical analyses were performed using the Statistical Package 
for the Social Sciences (version 23.0) [13].  Student’s t-test and 
Chi Square were used to compare group characteristics. Repeated 
measures ANOVA was used to assess change over time for primary 
outcomes, total narcotics use, and secondary outcomes, pain scores, 
and to compare the treatment assignment groups. Signifi cance was 
defi ned as p < 0.05.
Sample Size
Sample size was limited by the number of devices (n = 50) 
provided by the Sponsor.
RESULTS
Fift y patients were enrolled in the study ranging in age from 16 
- 40 years old and with a gestational age of 37 + 3 to 41 + 0 weeks. 
Forty patients were included in the data analysis. Ten patients were 
excluded from the analysis, including six who had premature catheter 
removal prior to the 48-hour time point related to excessive catheter 
leaking at skin insertion point or accidental or intentional patient 
self-removal, one due to an allergy requiring changes in narcotic 
medication, one for postpartum Ogilvie’s syndrome, and two 
who never had the wound irrigation system catheter placed due to 
complications at the time of surgery. Ten patients received epidural 
anesthesia, 28 patients received spinal anesthesia, and 2 patients 
received general anesthesia. All patients were followed for a period of 
48 hours. Comparison of the Bupivacaine and Saline groups revealed 
no diff erences with respect to clinical characteristics (see Table 1). 
Average total narcotic use at 6, 12, and 48 hours was lower in the 
Bupivacaine group compared to the Saline group, although these 
diff erences were not statistically signifi cant (p < 0.15, see Figure 1). At 
6, 12, and 48 hours post-operatively, the Bupivacaine group reported 
less pain than the Saline group, although not statistically signifi cant 
(p < 0.19; See Figure 2). Th e average narcotic use and pain scores at 
24 hours were higher in the Bupivacaine group than in the Saline 
group but failed to achieve signifi cance (narcotic use: 21.2mg ± 13.8 
Table 1: Clinical Characteristics of Bupivacaine versus Saline Groups.
Bupivacaine Group 
(n = 20)
Saline Group
(n = 20) p value
Age (mean ± sd) 25.1 ± 6.1 27.6 ± 5.9 ns
Gravida 3.8 ± 2.4 3.8 ± 2.6 ns
BMI 37.5 ± 5.9 35.5 ± 6.6 ns
Number Prior C - Sections 1.2 ± 1.3 1.0 ±1.1 ns
African American (% (n)) 50% (10) 60% (12) ns
Caucasian 35% (7) 25% (5) ns
Smoker 25% (5) 30% (6) ns
Epidural Anesthesia 25% (5) 25% (5) ns
Spinal Anesthesia 75% (15) 65% (13) ns
Figure 1: Average Narcotic Use at 6, 12, 24, and 48 Hours Post C-Section for 
Bupivacaine Versus Saline Groups.
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vs. 15.2mg ± 13.3, p < 0.15 and pain scores: 4.3 ± 2.5 vs. 3.5 ± 2.4, p < 
0.20). Additional analyses of women with prior C-section compared 
to those who were primagravida, revealed that in both Bupivacaine 
and Saline groups, women with a prior C-section had higher total 
narcotic use (38.3mg ± 20.8 vs. 58.1mg ± 27.5; p < 0.02) compared 
to primagravida women (Figure 3). Th e two groups did not diff er 
with respect to total narcotic use when race, age, smoking status, and 
BMI were controlled. Clinical characteristic for these two groups 
are presented in Table 2. With respect to anesthesia type, there were 
no diff erences in total narcotic use or average pain scores. Th e type 
of anesthesia dummy variables were entered into stepwise multiple 
regressions predicting total narcotics use and average pain scores, 
however, these variables did not enter the prediction equation. Only a 
history of previous Cesarean delivery predicted higher total narcotics 
use and higher average pain scores. 
DISCUSSION
Our study demonstrated that women who received the On-Q™ 
wound irrigation system at the sub-fascial and uterine incision planes 
demonstrated lower, but not statistically signifi cant, narcotics use and 
reduced pain across three of the four time points assessed (6 hr, 12 
hr, and 48 hr) leading to lower total narcotic use during the study. 
However, there was a peak of increased narcotic use and pain scores 
at the 24 hour time point. Regardless of study group assignment, 
patients with prior Cesarean sections had higher total narcotic use 
than women for whom this was their primary Cesarean section. Th e 
fi ndings of our study are consistent with the literature demonstrating 
no diff erences in total narcotics use and no diff erence in pain scores 
between patients receiving continuous wound irrigation and patients 
receiving intrathecal narcotics [14,15]. While our study is suggestive 
of lower narcotics use in the Bupivacaine group, the diff erence in 
pain scores was minimal. Th is is important because if patients are 
experiencing similar pain control and lower narcotics use, then the 
benefi ts of using the continuous wound irrigation method for post-
operative pain control will be evident through a decrease in narcotic 
side eff ects, including nausea and vomiting, but also by minimizing 
patient concerns regarding narcotic transmission in breastmilk and 
addiction potential. Th e sharp increase in narcotic use at the 24 hr 
time point and the accompanying spike in pain was an interesting 
fi nding, which may be accounted for by the earlier post-operative 
pain control. Some studies have noted that increased pain occurs 
around the time when IV medications are transitioned to oral therapy 
[16]. It is possible that earlier mobility at the 24-hour time point 
caused an increase in pain sensation, however, mobility parameters 
were not documented or included in data collection. Th e impact 
of prior Cesarean section on total narcotic use regardless of study 
group assignment,  may be attributed to increased pain related to 
previous scar tissue and increased manipulation during surgery or 
anticipated pain based on their previous experience during their prior 
Cesarean section leading to a tendency to over-medicate to avoid 
pain. Th e strengths of our study include that it was a randomized 
placebo controlled trial and that its approach included placement of 
the dual catheter at the uterine incision and between the fascia and 
rectus muscle. Th e study was designed to be executed in real time 
within the standards of post Cesarean wound management. Th e study 
was conducted on a resident service where all patients underwent 
standardized surgical procedures and postoperative care. Nursing 
staff  underwent study specifi c training to ensure that the required 
study information was recorded in the medical record. Placement of 
the wound irrigation system was informed by the current literature 
showing that placement below the fascia was more eff ective than 
placement above the fascia [12]. However, we acknowledge that there 
are study limitations including that not all cases were performed by 
the same surgeon and not all of the surgeons had extensive experience 
prior to the study for the placement or use of pain catheters at the 
time of Cesarean section. Th is likely contributed to some variance 
due to the learning curve associated with catheter placement. We 
Figure 2: Average Pain Score at 6, 12, 24, and 48 hours Post C-Section for 
Bupivacaine Versus Saline Groups.
Figure 3: Average Narcotic Use for women with and without Prior C-Section 
for Bupivacaine Saline Groups and combined Groups.
Women with Prior C-Section had higher narcotics use than Primagravida 
women (p<0.02 for the Combined Group comparison).
Table 2: Clinical Characteristics of Primagravida versus Prior Cesarean Section.
Primagravida
(n = 16)
1+ Prior C - 
Section (n = 24) p value
Age (mean ± sd) 24.1 ± 6.6 27.8 ± 5.3 < 0.07
Gravida 2.6 ± 2.5 4.6 ± 2.1 < 0.01
BMI 35.1 ± 5.4 37.4 ± 6.7 ns
Number Prior C - Sections 0.0 ± 0.0 1.8 ± 1.0 n/a
African American (% (n)) 50% (8) 58% (14) ns
Caucasian 37% (6) 25% (6) ns
Smoker 25% (4) 29% (7) ns
Epidural Anesthesia 63% (10) 0% (0) < 0.002
Spinal Anesthesia 37% (6) 92% (22) < 0.002
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experienced a large number of cases that were excluded from analysis 
which impacted power to detect diff erences. Our post hoc power 
analysis (power = 80%, p < 0.05) indicated that we would need 114 
patients per group to detect a diff erence in narcotics use (based on the 
group diff erence at the 48 hour time point) and 99 patients per group 
to detect a diff erence in pain score (based on the group diff erence at the 
48 hour time point) for the small eff ect sizes we had. Another possible 
limitation in this study was that we allowed diff erent anesthesia 
options including epidural, spinal, and general were used and not 
controlled. Th e study was executed in the standard labor and delivery 
setting in which anesthesia was determined according to patient desire 
and physician decision regarding what was in the best interest of the 
mother and infant. Further research is necessary with larger numbers 
of patients to allow inferences of no diff erence in pain scores using the 
dual catheter placement approach. Future studies will need to include 
specifi c assessment of side eff ects as this is an important area of patient 
concern with narcotics use. While patients may have experienced side 
eff ects, they may not have mentioned them to the nursing staff . If 
patients reported experiencing side eff ects, it is not known whether 
nurses would have recorded these in their notes unless the side eff ects 
were particularly bothersome and/or required intervention. As the 
culture of medicine changes over the next few years, it is important to 
improve patient satisfaction with their birthing experience for many 
reasons, including provider reimbursement. Th e nationwide rate of 
Cesarean section remains steady and pain control aft er surgery can 
be a major factor in patient satisfaction. Local infusion of anesthetic 
may allow patients to bond better with their babies, mobilize earlier, 
and possibly shorten length of stay when compared to traditional 
pain control methods. Our results show promise for the dual catheter 
placement for the management of postoperative pain and use of post-
operative narcotics. However, our study had insuffi  cient power, and 
we were unable to demonstrate a signifi cant diff erence between the 
Bupivacaine group and the Saline group. Further clinical trials with 
larger sample sizes are needed to address those patients at high risk 
of postoperative pain issues including individuals with substance 
abuse or undergoing repeat, classical or emergent Cesarean sections 
under general anesthetic. Furthermore, the optimal site for the On-Q 
wound irrigation system at either or both the sub-fascial and uterine 
incision warrants further investigation.
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